Clinical Trial Update: An Evaluation of Simvastatin Plus Omacor Compared to Simvastatin Plus Placebo in Subjects With Mixed Dyslipidemia

View source ↗

Summary

A completed clinical trial comparing simvastatin plus Omacor to simvastatin plus placebo in subjects with mixed dyslipidemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mixed Dyslipidemia

Drugs mentioned

• Omacor (omega-3-acid ethyl esters)
• SIMVASTATIN (SIMVASTATIN)

Snippet

Sponsor: Provident Clinical Research | Conditions: Mixed Dyslipidemia | Status: COMPLETED